CommercialCoverageMedium impact
Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease
Blue Cross & Blue Shield of Mississippi·MS · Infectious Disease, Internal Medicine, Family Medicine +4 more·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi has released a comprehensive medical policy for intravenous antibiotic therapy and diagnostic testing for Lyme disease. This policy establishes coverage criteria, diagnostic testing guidelines, and treatment protocols for various stages of Lyme disease including neuroborreliosis, Lyme carditis, and Lyme arthritis.
Action Required
Immediately: Review the complete Lyme disease policy at the provided URL to understand coverage criteria for IV antibiotic therapy and diagnostic testing. Clinical staff should familiarize themselves with the diagnostic testing protocols, including two-tiered serologic testing requirements and PCR testing guidelines for neuroborreliosis cases. Ensure documentation supports medical necessity for IV antibiotic therapy versus oral treatment based on disease stage and manifestations.